Search Orphan Drug Designations and Approvals
-
| Generic Name: | ganciclovir | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Name: | Zirgan | ||||||||||||||||
| Date Designated: | 03/22/2007 | ||||||||||||||||
| Orphan Designation: | Treatment of acute herpetic keratitis (dendritic and geographic ulcers) | ||||||||||||||||
| Orphan Designation Status: | Designated/Approved | ||||||||||||||||
| Sponsor: |
Sirion Therapeutics, Inc. 9314 East Broadway Avenue Tampa, Florida 33619 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
| 1 | Generic Name: | ganciclovir |
|---|---|---|
| Trade Name: | Zirgan | |
| Marketing Approval Date: | 09/15/2009 | |
| Approved Labeled Indication: | Treatment of acute herpetic keratitis (dendritic ulcers) | |
| Exclusivity End Date: | 09/15/2016 | |
| Exclusivity Protected Indication* : | ||
-
